Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer

Por Nakanishi, Shima, Cleveland, John L.
Publicado no Amino Acids (2016)

The Max Network Gone Mad

Por Baudino, Troy A., Cleveland, John L.
Publicado em 2001

Targeting lactate metabolism for cancer therapeutics

Por Doherty, Joanne R., Cleveland, John L.
Publicado em 2013

Tipping the MYC–MIZ1 balance: targeting the HUWE1 ubiquitin ligase selectively blocks MYC-activated genes

Por Schaub, Franz X, Cleveland, John L
Publicado no EMBO Mol Med (2014)

ATF4‐amino acid circuits: a recipe for resistance in melanoma

Por Fernandez, Mario R, Cleveland, John L
Publicado no EMBO J (2018)

Targeting the Autophagy Pathway for Cancer Chemoprevention

Por Steeves, Meredith A., Dorsey, Frank C., Cleveland, John L.
Publicado em 2010

Role of Polyamines in Immune Cell Functions

Por Hesterberg, Rebecca S., Cleveland, John L., Epling-Burnette, Pearlie K.
Publicado no Med Sci (Basel) (2018)

Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance

Por Carew, Jennifer S, Nawrocki, Steffan T, Giles, Francis J, Cleveland, John L
Publicado em 2008

Synthesis and Cytoxicity of Sempervirine and Analogues

Por Pan, Xiaohong, Yang, Chunying, Cleveland, John L., Bannister, Thomas D.
Publicado no J Org Chem (2016)

Apoptosis Triggered by Myc-Induced Suppression of Bcl-X(L) or Bcl-2 Is Bypassed during Lymphomagenesis

Por Eischen, Christine M., Woo, David, Roussel, Martine F., Cleveland, John L.
Publicado em 2001

Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1–dependent cellular transformation

Por Alt, Jodi R., Cleveland, John L., Hannink, Mark, Diehl, J. Alan
Publicado em 2000

CREB Targets Define the Gene Expression Signature of Malignancies Having Reduced Levels of the Tumor Suppressor Tristetraprolin

Por Fallahi, Mohammad, Amelio, Antonio L., Cleveland, John L., Rounbehler, Robert J.
Publicado no PLoS One (2014)

Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis

Por Eischen, Christine M., Roussel, Martine F., Korsmeyer, Stanley J., Cleveland, John L.
Publicado em 2001

Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis

Por Alt, Jodi R., Greiner, Timothy C., Cleveland, John L., Eischen, Christine M.
Publicado em 2003

Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis

Por Maclean, Kirsteen H., Dorsey, Frank C., Cleveland, John L., Kastan, Michael B.
Publicado em 2007

Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis

Por Maclean, Kirsteen H., Dorsey, Frank C., Cleveland, John L., Kastan, Michael B.
Publicado em 2008

CK1δ: an exploitable vulnerability in breast cancer

Por Rosenberg, Laura H., Cleveland, John L., Roush, William R., Duckett, Derek R.
Publicado no Ann Transl Med (2016)

Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis

Por Ruf, Ingrid K., Rhyne, Paul W., Yang, Chunying, Cleveland, John L., Sample, Jeffery T.
Publicado em 2000

Synthesis and SAR of Lehualide B – A Marine-derived Natural Product with Potent Anti-Multiple Myeloma Activity

Por Jeso, Valer, Yang, Chunying, Cameron, Michael D., Cleveland, John L., Micalizio, Glenn C.
Publicado em 2013

A Myc-Slug (Snail2)/Twist regulatory circuit directs vascular development

Por Rodrigues, Claudia O., Nerlick, Steve T., White, Elsie L., Cleveland, John L., King, Mary Lou
Publicado em 2008